This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Ratain, Mark J.
| Item Type | Name |
|
Concept
|
Protein Kinases
|
|
Concept
|
Mitogen-Activated Protein Kinases
|
|
Concept
|
Protein Kinase C
|
|
Concept
|
Protein Kinase C-alpha
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Academic Article
|
Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.
|
|
Academic Article
|
Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines.
|
|
Academic Article
|
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor.
|
|
Academic Article
|
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
|
|
Academic Article
|
Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension.
|
|
Academic Article
|
A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies.
|
|
Academic Article
|
Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases.
|
|
Academic Article
|
A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.
|
|
Academic Article
|
A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.
|
|
Academic Article
|
The UGT1A1*28 polymorphism correlates with erlotinib's effect on SN-38 glucuronidation.
|
|
Academic Article
|
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
|
|
Academic Article
|
Rapamycin: something old, something new, sometimes borrowed and now renewed.
|
|
Academic Article
|
Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors.
|
|
Academic Article
|
Playing Russian roulette with tyrosine kinase inhibitors.
|
|
Academic Article
|
Preventing adverse drug-drug interactions: a need for improved data and logistics.
|
|
Academic Article
|
Vemurafenib oral bioavailability: an insoluble problem.
|
|
Academic Article
|
Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial.
|
|
Academic Article
|
Influence of N-acetyltransferase 2 gene polymorphisms on the in vitro metabolism of the epidermal growth factor receptor inhibitor rociletinib.
|
|
Academic Article
|
Lorlatinib Exposed: A Far From Optimal Dose.
|